FBT vs. XLV
FBT (First Trust Amex Biotechnology Index) and XLV (State Street Health Care Select Sector SPDR ETF) are both Health & Biotech Equities funds - FBT tracks the NYSE Arca Biotechnology Index while XLV tracks the Health Care Select Sector Index. Both are passively managed. Over the past 10 years, FBT returned 10.45%/yr vs 9.86%/yr for XLV. A 0.71 correlation means they provide meaningful diversification when combined. FBT charges 0.57%/yr vs 0.08%/yr for XLV.
Performance
FBT vs. XLV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBT achieves a 11.27% return, which is significantly higher than XLV's -2.23% return. Over the past 10 years, FBT has outperformed XLV with an annualized return of 10.45%, while XLV has yielded a comparatively lower 9.86% annualized return.
FBT
- 1D
- 0.41%
- 1M
- 7.91%
- YTD
- 11.27%
- 6M
- 6.83%
- 1Y
- 44.08%
- 3Y*
- 13.78%
- 5Y*
- 6.30%
- 10Y*
- 10.45%
XLV
- 1D
- 0.88%
- 1M
- 0.56%
- YTD
- -2.23%
- 6M
- -2.55%
- 1Y
- 15.69%
- 3Y*
- 6.13%
- 5Y*
- 5.50%
- 10Y*
- 9.86%
FBT vs. XLV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 11.27% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
XLV State Street Health Care Select Sector SPDR ETF | -2.23% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
Correlation
The correlation between FBT and XLV is 0.67, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.67 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.67 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.67 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2006 | 0.71 |
The correlation between FBT and XLV has been stable across timeframes, ranging from 0.67 to 0.71 - a consistent structural relationship.
FBT vs. XLV - Sectors Allocation Comparison
Sectors
FBT
XLV
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBT
XLV
Basic Materials
FBT
-
XLV
-
Communication Services
FBT
-
XLV
-
Consumer Cyclical
FBT
-
XLV
-
Consumer Defensive
FBT
-
XLV
-
Energy
FBT
-
XLV
-
Financial Services
FBT
-
XLV
-
Industrials
FBT
-
XLV
-
Real Estate
FBT
-
XLV
-
Technology
FBT
-
XLV
-
Utilities
FBT
-
XLV
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT vs. XLV — Risk / Return Rank
FBT
XLV
FBT vs. XLV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FBT | XLV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.06 | ||
| Sortino ratioReturn per unit of downside risk | +1.35 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.19 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 3.11 | 1.51 | +1.60 |
| Martin ratioReturn relative to average drawdown | 9.19 | 3.56 | +5.62 |
Loading charts...
Drawdowns
FBT vs. XLV - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, roughly equal to the maximum XLV drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for FBT and XLV.
Loading charts...
Drawdown Indicators
| FBT | XLV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -39.17% | -1.34% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -10.47% | -3.79% |
Max Drawdown (3Y)Largest decline over 3 years | -20.05% | -17.11% | -2.94% |
Max Drawdown (5Y)Largest decline over 5 years | -28.98% | -17.11% | -11.87% |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | -28.40% | -3.97% |
Current DrawdownCurrent decline from peak | 0.00% | -5.53% | +5.53% |
Average DrawdownAverage peak-to-trough decline | -11.14% | -7.12% | -4.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.81% | 4.42% | +0.39% |
Volatility
FBT vs. XLV - Volatility Comparison
First Trust Amex Biotechnology Index (FBT) has a higher volatility of 6.54% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 5.14%. This indicates that FBT's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT | XLV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.54% | 5.14% | +1.40% |
Volatility (6M)Calculated over the trailing 6-month period | 16.15% | 10.58% | +5.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.06% | 15.06% | +6.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.88% | 14.76% | +7.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.88% | 16.59% | +7.29% |
FBT vs. XLV - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than XLV's 0.08% expense ratio.
Dividends
FBT vs. XLV - Dividend Comparison
FBT has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 2.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
XLV State Street Health Care Select Sector SPDR ETF | 2.11% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
FBT and XLV have a correlation of 0.67, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FBT has higher volatility (6.54%) compared to XLV (5.14%). In terms of maximum drawdown, FBT dropped -40.51% vs XLV's -39.17%.
On 10-year performance, FBT leads with 10.45% vs 9.86% for XLV. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 5.14%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FBT has performed better with a 10.45% return vs 9.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.57% for FBT.
XLV has the higher dividend yield at 2.11%, compared with 0.00% for FBT.
FBT tracks NYSE Arca Biotechnology Index, while XLV tracks Health Care Select Sector Index. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.57% for FBT and 0.08% for XLV.
FBT currently has the higher Sharpe Ratio (2.11 vs 1.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FBT and XLV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer